400 related articles for article (PubMed ID: 9883382)
21. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
22. Menstrual bleeding patterns in Norplant-2 implant users.
Biswas A; Leong WP; Ratnam SS; Viegas OA
Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
[TBL] [Abstract][Full Text] [Related]
23. Levonorgestrel capsule implants in the United States: a 5-year study.
Sivin I; Mishell DR; Darney P; Wan L; Christ M
Obstet Gynecol; 1998 Sep; 92(3):337-44. PubMed ID: 9721766
[TBL] [Abstract][Full Text] [Related]
24. A 5-year clinical evaluation of Norplant implants in Senegal.
Ba MG; Moreau JC; Sokal D; Dunson R; Dao B; Kouedou D; Diadhiou F
Contraception; 1999 Jun; 59(6):377-81. PubMed ID: 10518232
[TBL] [Abstract][Full Text] [Related]
25. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and experiences of American women electing for early removal of contraceptive implants.
Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
[TBL] [Abstract][Full Text] [Related]
27. New concepts in contraception: Norplant subdermal implant.
Lynn MM; Holdcroft C
Nurse Pract; 1992 Mar; 17(3):85-9. PubMed ID: 1565306
[TBL] [Abstract][Full Text] [Related]
28. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
[TBL] [Abstract][Full Text] [Related]
29. NORPLANT contraceptive implants advancing.
Segal SJ
Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
[TBL] [Abstract][Full Text] [Related]
30. Acceptability of Norplant-2 rods as a method of family planning.
Singh K; Viegas OA; Ratnam SS
Contraception; 1992 May; 45(5):453-61. PubMed ID: 1623717
[TBL] [Abstract][Full Text] [Related]
31. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
[TBL] [Abstract][Full Text] [Related]
32. A five-year clinical trial of levonorgestrel silastic implants (Norplant TM).
Diaz S; Pavez M; Miranda P; Robertson DN; Sivin I; Croxatto HB
Contraception; 1982 May; 25(5):447-56. PubMed ID: 6809423
[TBL] [Abstract][Full Text] [Related]
33. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
34. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
35. Experience with side effects and health risks associated with Norplant implant use in adolescents.
Rosenthal SL; Biro FM; Kollar LM; Hillard PJ; Rauh JL
Contraception; 1995 Nov; 52(5):283-5. PubMed ID: 8585884
[TBL] [Abstract][Full Text] [Related]
36. Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR; Blumenthal PD; Alvarez F; Brache V; Cochon L; Dalberth B; Glover L; Remsburg R; Vu K; Katz D
Fertil Steril; 1998 Feb; 69(2):258-66. PubMed ID: 9496339
[TBL] [Abstract][Full Text] [Related]
37. Assessing the acceptability of Norplant contraceptive in four patient populations.
Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
[TBL] [Abstract][Full Text] [Related]
38. [Norplant contraceptive implants: opinion of Dominican women who used this method].
Hardy E; Baez C; Faundes A; Alvarez F; Brache V
Acta Med Dom; 1990; 12(1):1-6. PubMed ID: 12292702
[TBL] [Abstract][Full Text] [Related]
39. A preliminary report of Norplant implant insertions in a large urban family planning program.
Crosby UD; Schwarz BE; Gluck KL; Heartwell SF
Contraception; 1993 Oct; 48(4):359-66. PubMed ID: 8222663
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
